1071 related articles for article (PubMed ID: 19702031)
1. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
Kircik L
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
[TBL] [Abstract][Full Text] [Related]
2. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
[TBL] [Abstract][Full Text] [Related]
3. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
Abramovits W
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
[TBL] [Abstract][Full Text] [Related]
4. Calcitriol ointment: optimizing psoriasis therapy.
Gold LF
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s23-7. PubMed ID: 19702033
[TBL] [Abstract][Full Text] [Related]
5. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
[TBL] [Abstract][Full Text] [Related]
6. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
Lahfa M; Mrowietz U; Koenig M; Simon JC
Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
[TBL] [Abstract][Full Text] [Related]
7. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis.
Langner A; Ashton P; Van De Kerkhof PC; Verjans H
Br J Dermatol; 1996 Sep; 135(3):385-9. PubMed ID: 8949430
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasis.
Lebwohl M; Ortonne JP; Andres P; Briantais P
Cutis; 2009 Apr; 83(4):205-12. PubMed ID: 19445311
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
Liao YH; Chiu HC; Tseng YS; Tsai TF
Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
[TBL] [Abstract][Full Text] [Related]
10. Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study.
Carboni I; de Felice C; Bergamin A; Chimenti S
J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():11-3. PubMed ID: 16274406
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin d3) for the treatment of psoriasis.
Pèrez A; Chen TC; Turner A; Raab R; Bhawan J; Poche P; Holick MF
Br J Dermatol; 1996 Feb; 134(2):238-46. PubMed ID: 8746336
[TBL] [Abstract][Full Text] [Related]
12. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
13. An open-label, multicenter study of the efficacy and safety of a weekday/weekend treatment regimen with calcitriol ointment 3 microg/g and clobetasol propionate spray 0.05% in the management of plaque psoriasis.
Hudson CP; Kempers S; Menter A; Papp K; Smith S; Sofen H; Colón LE; Johnson LA; Gottschalk R
Cutis; 2011 Oct; 88(4):201-7. PubMed ID: 22106730
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study.
Kragballe K; Fogh K; Søgaard H
Acta Derm Venereol; 1991; 71(6):475-8. PubMed ID: 1685828
[TBL] [Abstract][Full Text] [Related]
16. The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity.
Queille-Roussel C; Duteil L; Parneix-Spake A; Arsonnaud S; Rizova E
Eur J Dermatol; 2001; 11(3):219-24. PubMed ID: 11358728
[TBL] [Abstract][Full Text] [Related]
17. Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study.
Durakovic C; Ray S; Holick MF
Br J Dermatol; 2004 Jul; 151(1):190-5. PubMed ID: 15270890
[TBL] [Abstract][Full Text] [Related]
18. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
19. Calcipotriol ointment versus cream in psoriasis vulgaris.
Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
[TBL] [Abstract][Full Text] [Related]
20. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903).
Kragballe K
Arch Dermatol; 1989 Dec; 125(12):1647-52. PubMed ID: 2531570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
